Linked Life Data

2680907

Source:http://linkedlifedata.com/resource/pubmed/id/2680907

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2680907rdf:typepubmed:Citationlld:pubmed
pubmed-article:2680907lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0079460lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0011306lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0034819lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0871161lld:lifeskim
pubmed-article:2680907lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2680907pubmed:issue1lld:pubmed
pubmed-article:2680907pubmed:dateCreated1989-12-5lld:pubmed
pubmed-article:2680907pubmed:abstractTextFresh lymph-borne (veiled) dendritic cells (L-DC) in the rat are almost totally negative for the interleukin-2 (IL-2) receptor detected by the monoclonal antibody (mAb) MRC OX39. After 16 hr culture more than 90% of L-DC are OX39 positive, and increased levels of expression can be seen within 5 hr culture. In cultures of L-DC and allogeneic lymphocytes. L-DC appear to express the IL-2 receptor more rapidly than lymphocytes. The intensity of labelling of L-DC is variable but maximal levels are similar to those seen on lymphoblasts. Culture in the presence of concanavalin A (Con A)-stimulated spleen cell supernatants or recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) results in a more rapid and intense expression of the IL-2 receptor by L-DC. L-DC cultured following rigorous T-cell depletion, or derived from athymic rats also express the IL-2 receptor after culture with GM-CSF. Cultured, but not fresh, L-DC bind iodinated recombinant IL-2 in a dose-dependent manner and binding is inhibited by excess unlabelled ligand. The amount of IL-2 bound varies but maximal amounts are similar to those bound by lymphoblasts. Following intravenous endotoxin injection, a large proportion of freshly collected L-DC express the IL-2 receptor and the number of L-DC released into the lymph is increased. An antibody to the IL-2 receptor which blocks an allogeneic MLR has no effect on a xenogeneic MLR using rat L-DC as stimulators and mouse lymphocytes as responders.lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:languageenglld:pubmed
pubmed-article:2680907pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:citationSubsetIMlld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2680907pubmed:statusMEDLINElld:pubmed
pubmed-article:2680907pubmed:monthSeplld:pubmed
pubmed-article:2680907pubmed:issn0019-2805lld:pubmed
pubmed-article:2680907pubmed:authorpubmed-author:FossumSSlld:pubmed
pubmed-article:2680907pubmed:authorpubmed-author:HarrisonBBlld:pubmed
pubmed-article:2680907pubmed:authorpubmed-author:MacPhersonG...lld:pubmed
pubmed-article:2680907pubmed:issnTypePrintlld:pubmed
pubmed-article:2680907pubmed:volume68lld:pubmed
pubmed-article:2680907pubmed:ownerNLMlld:pubmed
pubmed-article:2680907pubmed:authorsCompleteYlld:pubmed
pubmed-article:2680907pubmed:pagination108-13lld:pubmed
pubmed-article:2680907pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:meshHeadingpubmed-meshheading:2680907-...lld:pubmed
pubmed-article:2680907pubmed:year1989lld:pubmed
pubmed-article:2680907pubmed:articleTitleProperties of lymph-borne (veiled) dendritic cells in culture. II. Expression of the IL-2 receptor: role of GM-CSF.lld:pubmed
pubmed-article:2680907pubmed:affiliationSir William Dunn School of Pathology, Oxford, U.K.lld:pubmed
pubmed-article:2680907pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2680907lld:pubmed